Sanofi Long-Term Concentrated

Location: Paris, France

CIK: 0001121404 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Jul 29, 2025

Total Value: $176M (100.0% shares, 0.0% debt)

Holdings (10)

MGTX MeiraGTx Holdings plc 45.3%

Value $79.53M Shares 12,197,737 Est. Cost $5.86 Unrealized +0.8%

NVAX Novavax 24.7%

Value $43.35M Shares 6,880,481 Est. Cost $9.64 Unrealized -31.3%

ANAB AnaptysBio 10.4%

Value $18.25M Shares 821,917 Est. Cost $24.22 Unrealized -13.6%

INBX Inhibrx Biosciences, Inc. 9.4%

Value $16.52M Shares 1,157,926 Est. Cost $15.23 Unrealized -15.1%

OMDA Omada Health Inc. 5.5%

Value $9.606M Shares 524,903 Est. Cost $17.31 Unrealized 0.0%

— LAVA Therapeutics N.V. 1.4%

Value $2.534M Shares 1,919,455 Est. Cost $0.95 Unrealized —

ELDN Eledon 1.3%

Value $2.209M Shares 814,980 Est. Cost $3.94 Unrealized -23.9%

— Inozyme, Inc 1.0%

Value $1.773M Shares 443,255 Est. Cost $2.77 Unrealized —

— IGM Biosciences 0.9%

Value $1.612M Shares 1,438,975 Est. Cost $6.11 Unrealized —

QTTB Q32 Bio Inc. 0.2%

Value $364K Shares 244,083 Est. Cost $31.58 Unrealized -94.6%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
MGTX	MeiraGTx Holdings plc	12,197,737	$79.53M	45.3%	$5.86	+0.8%	COM	G59665102
NVAX	Novavax	6,880,481	$43.35M	24.7%	$9.64	-31.3%	COM NEW	670002401
ANAB	AnaptysBio	821,917	$18.25M	10.4%	$24.22	-13.6%	COM	032724106
INBX	Inhibrx Biosciences, Inc.	1,157,926	$16.52M	9.4%	$15.23	-15.1%	COM	45720N103
OMDA	Omada Health Inc.	524,903	$9.606M	5.5%	$17.31	0.0%	COM	68170A108
—	LAVA Therapeutics N.V.	1,919,455	$2.534M	1.4%	$0.95	—	SHS	N51517105
ELDN	Eledon	814,980	$2.209M	1.3%	$3.94	-23.9%	COM	28617K101
—	Inozyme, Inc	443,255	$1.773M	1.0%	$2.77	—	COM	45790W108
—	IGM Biosciences	1,438,975	$1.612M	0.9%	$6.11	—	COM	449585108
QTTB	Q32 Bio Inc.	244,083	$364K	0.2%	$31.58	-94.6%	COM	746964105